PTSM: Pharmaceutical Technology Sourcing and Management
CDMO Vetter produces identifiable labeling for a top-ten pharmaceutical company.
Vetter has announced that it has manufactured the first commercial batches with single-use identification numbers and implemented product serialization for secondary packaging in accordance with the requirements from the South Korean Ministry of Food and Drug Safety (MFDS). The Vetter solution identifies the drugs on the folding boxes via a 2-D data matrix code with a serial number, GTIN, expiry date, and batch number.
To combat counterfeit drugs, regulatory authorities worldwide are requiring clear identification of products through serialization; the smallest packaging unit must be marked with a single-use identification number. South Korea is among those countries requiring serialization with an aim towards protecting against counterfeiting, as well as a more secure supply chain.
Presently, South Korea has only asked for serialization on the folding package. China has legislated use of 1-D linear codes including aggregation with the shipping box.
Vetter provides services in secondary packaging, primary packaging, and final assembly to accommodate various regulatory or market needs. The company's serialization service includes a range of formats for serial numbers, different code systems, interfaces, and reports, as well as various aggregation depths.
Source: Vetter
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.